1.Effect of dyslipidemia on clinical outcome of infertility patients receiving donor eggs
Yuan ZHANG ; Caihe WEN ; Xinru XIA ; Jing WANG ; Meng XIA ; Yi QIAN ; Li SHU ; Jiayin LIU ; Daowu WANG ; Xiang MA
Chinese Journal of Obstetrics and Gynecology 2022;57(9):686-691
Objective:To explore the effect of dyslipidemia on the clinical outcome of intracytoplasmic sperm injection-embryo transfer (ICSI-ET) in infertility patients receiving donor eggs.Methods:A total of 118 patients were selected to receive egg donors and ICSI-ET at the First Affiliated Hospital of Nanjing Medical University between April 2007 and December 2020. According to the levels of triacylglycerol, serum cholesterol, high density lipoprotein (HDL), and low density lipoprotein, they were divided into dyslipidemia group (35 cases) and normal blood lipids group (83 cases). The influence of body mass index (BMI) and age was adjusted by 1∶1 propensity score matching, and the general condition and clinical outcome of the two groups were analyzed retrospectively. Finally, the relationship between lipid composition and clinical outcome was analyzed according to patients′ age and BMI.Results:(1) Comparing the pre-matching dyslipidemia group with the normal blood lipids group, the BMI of the dyslipidemia group was significantly higher than that of the normal blood lipids group [(23.5±2.4) vs (22.4±2.7) kg/m 2], and the embryo implantation rate was significantly lower than that of the normal blood lipids group [13.6% (8/59) vs 27.3% (36/132)], the differences were statistically significant (both P<0.05). (2) There were no significant differences in years of infertility, number of pregnancies, number of abortions, number of transplanted embryos, protocol of endometrial preparation, endometrial thickness on transplantation day and high quality embryo rate between the two groups, through propensity score matching (all P>0.05). The biochemical pregnancy rate [28.6% (10/35)], embryo implantation rate [13.6% (8/59)] and live birth rate [20.0% (7/35)] in dyslipidemia group were significantly lower than those in the normal blood lipids group ( P<0.05). The clinical pregnancy rate was lower than that of the normal blood lipids group ( P>0.05). (3) The results of stratified analysis showed that the level of HDL in the clinically non-pregnant group was significantly lower than that in the pregnant group in patients ≤ 35 years old [(1.5±0.3) vs (1.8±0.5) mmol/L; P<0.05]. In the overweight recipient patients, the level of HDL of the clinically non-pregnant group was lower than that of the pregnant group ( P>0.05). Conclusions:Dyslipidemia significantly reduces the biochemical pregnancy rate, embryo implantation rate and live birth rate in patients with receiving donor eggs. Especially in patients aged ≤35 years old, the reduction of HDL is closely related to adverse pregnancy outcomes.
2.Comparative Study and Reference of Children ’s Edition of WHO ,British and Chinese National Formulary
Xinru MENG ; Jiping HUO ; Weizhong SHI ; Zhigang ZHAO
China Pharmacy 2019;30(9):1158-1164
OBJECTIVE: To provide reference for the revision of China National Formulary for Children and make a sample for Chinese medical institutions to formulate their own formulary. METHODS: The suggestions on formulary revision and the formulation of formulary in medical institutions were put forward through comparing the selection principle, catalogues, chapters, drug items, formulary quantity and coincident drugs of World Health Organization (WHO) Model Formulary for Children (2010 edition) (WMFc), British National Formulary (Children edition) (2016-2017 edition) (BNFc), Chinese National Formulary (Children edition) (2013 edition) (CNFc). RESULTS & CONCLUSIONS: The selection principle of WMFc was safe, effective and economical; that of BNFc was accurate and up-to-date, that of CNFc was safe, effective, economical and appropriate. The catalogues of three formularies included introduction, outline and separated section, but the contents or descriptions were different. For example, in separated section, WMFc was divided into 27 chapters, BNFc was divided into 16 chapters and CNFc was divided into 20 chapters. The chapters and catalogues of WMFc were classified according to ATC; those of BNFc were classified according to organ system and disease arrangement; those of CNFc were classified according to disease treatment system. 15 chapters of three formularies were the same, such as drug for nervous system diseases, drug for endocrine system and drug for respiratory system. The unique chapter of CNFc was “drugs for stomatological diseases”. The drug items of three formularies included drug name, indications, usage and dosage, contraindication, ADR, matters need attention, preparation and specifications, etc. Compared with CNFc, unique chapters of WMFc included ATC numbering, drug interaction, liver injury, etc.; those of BNFc included pharmacological action, interaction, allergy, etc. WMFc contained 271 drugs, CNFc 847 drugs and BNFc 955 drugs. Among them, there were 166 overlaps between WMFc and CNFc, 359 between BNFc and CNFc, 174 between WMFc and BNFc. There were 141 same drugs in the three formularies. When revising or formulating formulary, our country should not copy them mechanically, but should revise formulary according to our national conditions. It is necessary to refer to selection principles of WMFc and BNFc, update our children’s formulary in certain or real time, standardize drug access criteria of formulary, rationally increase the variety of drug and call on the relevant departments of the state to improve the standards for the formulation of drug instructions for children.
3.Discussion on Differentiation and Treatment of Sudden Hearing Loss by Traditional Chinese Medicine Based on the Classification of Hearing Curve
Xinru WANG ; Yang LI ; Jiajia ZHANG ; Yan MENG ; Chongyang ZHANG ; Xueshi DI ; Zhiwei FENG ; Junjie LIANG ; Peng BAI
Journal of Traditional Chinese Medicine 2024;65(11):1126-1131
Pure-tone audiometry can be performed to evaluate the type and degree of hearing loss, whose results can be divided into four types including low-frequency descending, high-frequency descending, flat descending and total deafness. The low-frequency descending type of sudden hearing loss (SHL) is more likely to be spleen deficiency and dampness exuberance, the high-frequency descending type is often due to yin deficiency of liver and kidney, the flat descending type is commonly associated with qi and blood depletion, and the type of total deafness is often linked to blood stasis. Our team has further developed a comprehensive diagnostic and therapeutic approach for SHL, emphasizing "the integration of disease and syndrome, the combination of acupuncture and herbal medicine, and dynamically administering treatment". Firstly, it advocates integrating disease diagnosis with syndrome differentiation. Secondly, it recommends combining acupuncture and herbal medicine, with local acupoints such as Ermen (TE 21), Tinggong (SI 19), Tinghui (GB 2), and Yifeng (TE 17) used to unblock the auditory orifice, and herbal prescriptions tailored to the hearing curve patterns. For the low-frequency descending type, it is recommended to fortify the spleen and percolate dampness by taking distal points of spleen channel and stomach channel and using Shenling Baizhu Powder (参苓白术散). For the high-frequency descending type, the method of nourishing kidney and calming liver is recommended, using distal points of kidney and liver channels and taking Erlong Zuoci Pills (耳聋左慈丸). Regarding the flat descending type, tonifying qi and nourishing blood is advised, for which acupoints of Conception Vessel, spleen, stomach and large intestine channels can be needled, and Yiqi Congming Decoction (益气聪明汤) can be administered. For the total deafness type, it is recommended to activate blood and dissipate stasis, often with Xuehai (SP 10) and Geshu (BL 17) needled and Tongqiao Huoxue Decoction (通窍活血汤) administered. All these are conducted to treat the root and branch simultaneously. At the same time, it emphasizes the need to consider complex syndrome presentations and disease progression, dynamically analyze the disease causes and mechanisms, and adjust treatment according to the changing syndromes. In conclusion, this article is expected to inspire clinical diagnosis and treatment of SHL.
4.International and domestic researches about neurogenic bladder: a visualized analysis
Xiangzhi MENG ; Shenhong CUI ; Xiaoqian HOU ; Benyuan LI ; Xinru ZHANG ; Ping ZHANG ; Yunbo HAN ; Jun LENG
Chinese Journal of Rehabilitation Theory and Practice 2022;28(4):439-446
Objective To evaluate the development, hot spots and trends of the fields of neurogenic bladder.Methods The relevant articles of neurogenic bladder from January, 2000 to June, 2021 in CNKI and Web of Science were retrieved.The countries, authors, institutions, cited reference and keywords were extracted with CiteSpace to draw knowledge mapping. Results and Conclusion A total of 5 064 articles were enrolled. At present, the research on the field of neurogenic bladder is in a stable period of development, and this field has been widely concerned by scholars at home and abroad. The cooperation between domestic authors and institutions is not close enough compared with foreign countries, and domestic cooperation is more between medical schools and their respective affiliated hospitals. In the future, China can further strengthen cross-regional and cross-agency cooperation. Low-frequency electrical stimulation and sacral nerve regulation are seem to be research hotspots, and children's neurogenic bladder and robot-assisted technologies are also needed more attention.